FSD Pharma Announces Engagement with Capital Markets Communications Providers and Market Maker
September 22 2021 - 6:30PM
Business Wire
FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD
Pharma” or the “Company”), a life sciences holding
company dedicated to building a portfolio of assets and biotech
solutions, announced today it has retained the services of Hybrid
Financial Ltd. (“Hybrid”), North Equities Corp. (the
"North Equities"), Looking Glass Capital Consultants
(“Looking Glass”), Worldwide Media Solutions, LLC
(“BGTV Direct”), KCSA Strategic Communications
("KCSA"), and Digi Messaging & Advertising
(“Digi”), which will each play a key role in assisting the
Company to enhance its market awareness and foster productive,
continuing dialogues with shareholders and other market
participants. Management has made this decision following a
thorough review of capital on hand and allocated these resources to
investor relations.
Toronto-based Hybrid has been engaged for twelve months, during
which it will assist in all aspects of a marketing campaign for the
Company (contract signed August 25 ,2021). As consideration for its
services, the Company will pay Hybrid a monthly fee of US$22,500,
to be paid by issuing Hybrid 160,714 common shares of the Company
(“FSD Shares”) at a price equal to US$1.68. The FSD Shares will be
subject to the statutory hold period of four months and one
day.
North Equities, which is also based in Toronto, specializes in
various social media platforms, and will assist the Company in
improving awareness and dissemination of its news releases. North
Equities' engagement is for a term of seven months (contract signed
July 23, 2021). In consideration for its services, the Company has
agreed to pay North Equities a total fee of 42,918 common shares of
the Company (“FSD Shares”) at a price equal to US$1.68. The FSD
Shares will be subject to the statutory hold period of four months
and one day.
Looking Glass, which is based in New York has been engaged
monthly to assist with market awareness for a fee of US$25,000 per
month. This contract was signed June 22, 2021.
BGTV, which is based in Las Vegas has been engaged monthly to
assist in multi-media production, programming, and distribution of
Company information. In consideration for its services, the Company
will pay to BGTV a monthly fee of US$42,500. This contract was
signed August 8, 2021.
KCSA, a leading New York City-based communications firm, has
been engaged month to month to develop strategic communications.
The Company will pay to KCSA a monthly fee of US$25,000. This
contract was signed September 14, 2021.
Digi, which is based in Casper USA, has been engaged monthly to
assist with marketing services. The Company will pay Digi a monthly
fee of US$50,000 as well as issuing to Digi 16,304 FSD Shares at a
price equal to US$1.84. The FSD Shares will be subject to the
statutory hold period of four months and one day. This contract was
signed August 5, 2021.
Except as described in this news release, none of Hybrid, North
Equities, Looking Glass, BGTV, KCSA and Digi has any interest,
directly or indirectly, in the Company or its securities, or any
right or intent to acquire such an interest. All amounts payable to
these advisors will be paid from the Company’s working capital on
hand.
The Company has also retained Integral Wealth Securities Limited
("Integral") to provide market-making services. Integral
will trade shares of the Company on the Canadian Securities
Exchange to maintain an orderly market, improve the liquidity of
the Company's shares and provide the Company with market
intelligence. Under the terms of the agreement, Integral will
receive a fee of $6,000 per month for a minimum period of three
months. After the initial three-month period, the agreement may be
terminated by the Company at any time upon 30 days' written notice.
The Company and Integral are unrelated entities. Integral has no
present, direct or indirect interest in the Company or its
securities. There are no performance factors in the agreement, and
Integral will not receive shares or options as compensation.
Integral is a member of the Investment Industry Regulatory
Organization of Canada ("IIROC"). Accordingly, Integral can
access all Canadian Stock Exchanges and Alternative Trading
Systems. The contract for Integral was signed September 3, 2021.
The company have also engaged Red Cloud securities for
market-making services on a month-to-month basis and they will
receive a fee of $7,000/month. The Company and Red Cloud are
unrelated entities. Red Cloud has no present, direct or indirect
interest in the Company or its securities. The contract for Red
Cloud securities was signed September 7, 2021.
About FSD Pharma
FSD Pharma is a life sciences holding company dedicated to
building a portfolio of diversified therapeutic assets and
innovative healthcare and biotech services. Currently, FSD is
actively pursuing potential acquisition targets in the healthcare
and biotech space to bring innovative treatments to market to treat
various mental health disorders and neurodegenerative diseases.
Forward Looking Information
Certain statements included in this press release constitute
forward-looking information or statements (collectively,
“forward-looking statements”), including those identified by the
expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”,
“intend”, “may”, “should” and similar expressions to the extent
they relate to the Company or its management. The forward-looking
statements are not historical facts but reflect current
expectations regarding future results or events. This press release
contains forward looking statements, including but not limited to
statements regarding the terms and deliverables of the various
agreements. These forward-looking statements are based on current
expectations and various estimates, factors and assumptions and
involve known and unknown risks, uncertainties, and other
factors.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210922006009/en/
For further information: Zeeshan Saeed, President,
Founder and Director, FSD Pharma Inc. Email: zeeshan@fsdpharma.com,
Telephone: (416) 854-8884 Investor Relations: Email:
ir@fsdpharma.com, Website: www.fsdpharma.com
FSD Pharma (NASDAQ:HUGE)
Historical Stock Chart
From Mar 2024 to Apr 2024
FSD Pharma (NASDAQ:HUGE)
Historical Stock Chart
From Apr 2023 to Apr 2024